Table 3 Univariate analysis of predictive factors for a good therapeutic response to anakinra or tocilizumab (n = 25)
From: Adult-onset Still’s disease biological treatment strategy may depend on the phenotypic dichotomy
From: Adult-onset Still’s disease biological treatment strategy may depend on the phenotypic dichotomy